icon-folder.gif   Conference Reports for NATAP  
61th Annual Meeting of the American Association for the Study of Liver Diseases
Boston, MA, Hynes Convention Center
October 30-November 3, 2010
Back grey_arrow_rt.gif
Safety, Pharmacokinetics, and Antiviral Activity of Single Oral Doses of the HCV NS3 Protease Inhibitor GS-9256
  Reported by Jules Levin
AASLD 2010 Nov 2 Boston
R Goldwater1, M DeMicco2, J Zong3, G Chittick3, G Yuen3, S West3, J Kagel3, A Bae3, H Mo3, D Oldach3, W Delaney3, and J Findlay3 1PAREXEL International, Baltimore, MD, 2Advanced Clinical Research Institute, Anaheim, CA, 3Gilead Sciences, Foster City, CA.